United Kingdom · Question · Written question
UIN 8799
Prostate Cancer: Radiotherapy
Introduced
10 June 2026
Last action
16 June 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
16 June 2026
Summary
To ask the Secretary of State for Health and Social Care, what estimate he has made of the average travel distance for patients accessing SABR treatment for prostate cancer.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
10 June 2026
Written question
To ask the Secretary of State for Health and Social Care, what estimate he has made of the average travel distance for patients accessing SABR treatment for prostate cancer.
Source: Commons
16 June 2026
Answer
The clinical commissioning policy for stereotactic ablative radiotherapy (SABR) for localised prostate cancer was supported by an Equality and Health Inequalities Impact Assessment. This identified several potential benefits for patients, including fewer ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-06-10/8799
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1914868
- uk · wq-1914868 · source updated 16 June 2026